The Use of BiPAP on COPD Patients

Introduction BiPAP is a noninvasive ventilator for patients with acute respiratory failure. Many of these patients are contagious due to non-invasive ventilation based on deterioration of COPD, congestive heart failure, and ventilator parameters and clinical assessment of arterial blood gas. For COPD patients, two different studies were conducted using the BiPAP device, and their exacerbation and activities of daily living were improved. These noninvasive ventilators have many positive results, but when used incorrectly, there is always the possibility of negative results, or there may be no change at all.

COPD = chronic obstructive pulmonary disease; CPAP = positive positive airway pressure; biPAP = biphasic positive airway pressure; RDS = respiratory distress syndrome; BPD = bronchopulmonary dysplasia; SIDS = sudden infant death syndrome CVA = cerebrovascular disorder; CA = cancer; TENS = percutaneous electrical nerve stimulation

Summary: COPD is the leading cause of global morbidity and mortality. The patient has intractable dyspnea, unrecognized anxiety and depression, and a decline in the quality of life. Most of the patients with COPD could not receive palliative care, but palliative care improved symptom management, and patients reported health-related quality of life, cost savings, and mortality. There are many obstacles to providing palliative care to patients with COPD. There are difficulties in predicting the course of the patient's illness that leads to introductions that occur during the patient's disease progression phase. In addition, as COPD patients have unique communication barriers, doctors avoid conversations about pre-treatment planning. Finally, many medical systems have not been established to provide palliative care physicians trained in patients with chronic disease.

For patients diagnosed with COPD, the reality of disease limiting life causing serious breathing difficulties is often terrible. Predicting prognosis is difficult for their clinician. In this week's "Lancet" magazine, a series of papers are discussing palliative care for patients with COPD and are part of the agenda of the European Respiratory Society International Conference to be held in Milan on September 12. The median symptoms of COPD patients are 11 to 14, with breathing difficulties, cough, fatigue, anxiety, depression, insomnia and pain. Non-pharmacological and pharmacological approaches to managing symptoms can improve the quality of life. Fear of the end will often appear, but rarely discussed. For patients with COPD, life expectancy may be improved by early combining palliative care and respiration, primary care and rehabilitation services, and referral based on symptom complexity rather than prognostic prediction